PERCEPTIVE ADVISORS LLC Insider Trading Transactions
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
May 07 2021 | MNLO | VYNE Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.67 | 1,000,000 | 3,670,000 | 5,773,954 | 6.8 M to 5.8 M (-14.76 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,195,792 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 949,992 | 0 | 0 | |
Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 2,537,019 | 2 M to 2.5 M (+27.68 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,107,316 | 0 | 1,987,019 | 879.7 K to 2 M (+125.87 %) |
Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 879,703 | 0 | 879,703 | 0 to 879.7 K |
Apr 06 2021 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 2.87 | 450,000 | 1,291,500 | 450,000 | |
Mar 23 2021 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 5.75 | 2,608,695 | 14,999,996 | 13,412,552 | 10.8 M to 13.4 M (+24.15 %) |
Mar 16 2021 | RXDX | Prometheus Bioscie ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 14,462,623 | 0 | 0 | |
Mar 16 2021 | RXDX | Prometheus Bioscie ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 10,177,703 | 0 | 0 | |
Mar 16 2021 | RXDX | Prometheus Bioscie ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 19.00 | 850,000 | 16,150,000 | 3,314,032 | 2.5 M to 3.3 M (+34.50 %) |
Mar 16 2021 | RXDX | Prometheus Bioscie ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,446,262 | 0 | 2,464,032 | 1 M to 2.5 M (+142.10 %) |
Mar 16 2021 | RXDX | Prometheus Bioscie ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,017,770 | 0 | 1,017,770 | 0 to 1 M |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 14.60 | 34,951 | 510,285 | 7,299,751 | 7.3 M to 7.3 M (+0.48 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 13.80 | 64,730 | 893,274 | 7,264,800 | 7.2 M to 7.3 M (+0.90 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 13.10 | 1,771 | 23,200 | 7,200,070 | 7.2 M to 7.2 M (+0.02 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 12.53 | 86,671 | 1,085,988 | 7,198,299 | 7.1 M to 7.2 M (+1.22 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 11.38 | 34,611 | 393,873 | 7,111,628 | 7.1 M to 7.1 M (+0.49 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 11.14 | 27,453 | 305,826 | 7,077,017 | 7 M to 7.1 M (+0.39 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,770,600 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,857,795 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,857,795 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,941,769 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,941,769 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 1,250,000 | 20,000,000 | 7,049,564 | 5.8 M to 7 M (+21.55 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 1,770,600 | 0 | 1,770,600 | 0 to 1.8 M |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,857,795 | 0 | 5,799,564 | 2.9 M to 5.8 M (+97.15 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,857,795 | 0 | 5,799,564 | 2.9 M to 5.8 M (+97.15 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,941,769 | 0 | 2,941,769 | 0 to 2.9 M |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,941,769 | 0 | 2,941,769 | 0 to 2.9 M |
Feb 03 2021 | CATB | CATABASIS PHARMACE ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 0.00 | 1,617 | 0 | 30,920 | |
Feb 03 2021 | CATB | CATABASIS PHARMACE ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 0.00 | 4,851 | 0 | 4,851 | |
Feb 01 2021 | MNLO | VYNE Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.37 | 4,219,409 | 9,999,999 | 27,095,819 | 22.9 M to 27.1 M (+18.44 %) |
Jan 27 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 22.50 | 311,111 | 6,999,998 | 3,425,916 | 3.1 M to 3.4 M (+9.99 %) |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 8.95 | 33,849 | 302,949 | 1,800,000 | 1.8 M to 1.8 M (-1.85 %) |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 8.16 | 285,151 | 2,326,832 | 1,833,849 | 2.1 M to 1.8 M (-13.46 %) |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 7.38 | 95,000 | 701,100 | 2,120,000 | 2.2 M to 2.1 M (-4.29 %) |
Jan 26 2021 | SCYX | SCYNEXIS INC | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 7.43 | 185,000 | 1,374,550 | 2,215,000 | 2.4 M to 2.2 M (-7.71 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.48 | 550,000 | 814,000 | 2,660,542 | 3.2 M to 2.7 M (-17.13 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.68 | 674,352 | 1,132,911 | 3,210,542 | 3.9 M to 3.2 M (-17.36 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.80 | 325,648 | 586,166 | 3,884,894 | 4.2 M to 3.9 M (-7.73 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.48 | 550,000 | 814,000 | 2,660,542 | 3.2 M to 2.7 M (-17.13 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.68 | 674,352 | 1,132,911 | 3,210,542 | 3.9 M to 3.2 M (-17.36 %) |
Jan 22 2021 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 1.80 | 325,648 | 586,166 | 3,884,894 | 4.2 M to 3.9 M (-7.73 %) |
Jan 21 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.50 | 1,368,421 | 13,000,000 | 8,703,879 | 7.3 M to 8.7 M (+18.65 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.60 | 50,000 | 380,000 | 7,335,458 | 7.3 M to 7.3 M (+0.69 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.21 | 152,668 | 1,558,740 | 7,285,458 | 7.1 M to 7.3 M (+2.14 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.21 | 347,332 | 3,198,928 | 7,132,790 | 6.8 M to 7.1 M (+5.12 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 8.13 | 500,000 | 4,065,000 | 6,785,458 | 6.3 M to 6.8 M (+7.95 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.60 | 50,000 | 380,000 | 7,335,458 | 7.3 M to 7.3 M (+0.69 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.21 | 152,668 | 1,558,740 | 7,285,458 | 7.1 M to 7.3 M (+2.14 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 9.21 | 347,332 | 3,198,928 | 7,132,790 | 6.8 M to 7.1 M (+5.12 %) |
Jan 11 2021 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 8.13 | 500,000 | 4,065,000 | 6,785,458 | 6.3 M to 6.8 M (+7.95 %) |
Dec 15 2020 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Grant | A | 3.70 | 4,054,054 | 15,000,000 | 10,803,857 | 6.7 M to 10.8 M (+60.06 %) |
Oct 22 2020 | ARYB | ARYA Sciences Acqu ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 10.09 | 43,195 | 435,838 | 157,295 | 114.1 K to 157.3 K (+37.86 %) |
Oct 22 2020 | ARYB | ARYA Sciences Acqu ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 10.09 | 43,195 | 435,838 | 157,295 | 114.1 K to 157.3 K (+37.86 %) |
Oct 22 2020 | ARYB | ARYA Sciences Acqu ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 10.00 | 114,100 | 1,141,000 | 114,100 | 0 to 114.1 K |
Oct 22 2020 | ARYB | ARYA Sciences Acqu ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 10.00 | 114,100 | 1,141,000 | 114,100 | 0 to 114.1 K |
Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,644,785 | 0 | 0 | |
Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 3,114,805 | 2.1 M to 3.1 M (+51.50 %) |
Sep 22 2020 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,644,785 | 0 | 2,055,981 | 411.2 K to 2.1 M (+400.00 %) |
Sep 16 2020 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.25 | 2,911,764 | 12,374,997 | 16,200,818 | 13.3 M to 16.2 M (+21.91 %) |
Sep 15 2020 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 40.00 | 400,000 | 16,000,000 | 2,360,139 | 2 M to 2.4 M (+20.41 %) |
Sep 14 2020 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.00 | 1,800,000 | 19,800,000 | 13,532,467 | 11.7 M to 13.5 M (+15.34 %) |
Sep 14 2020 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 11.24 | 200,000 | 2,248,000 | 11,732,467 | 11.5 M to 11.7 M (+1.73 %) |
Jul 13 2020 | ALDX | Aldeyra Therapeuti ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.25 | 3,200,000 | 13,600,000 | 6,285,458 | 3.1 M to 6.3 M (+103.71 %) |
Jun 24 2020 | LPTX | LEAP THERAPEUTICS, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.00 | 1,750,000 | 3,500,000 | 8,476,496 | 6.7 M to 8.5 M (+26.02 %) |
Jun 18 2020 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 3.03 | 30,000 | 90,900 | 30,000 | |
Jun 11 2020 | MNLO | Menlo Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.85 | 2,702,702 | 4,999,999 | 22,876,410 | 20.2 M to 22.9 M (+13.40 %) |
Jun 04 2020 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 13.85 | 25,000 | 346,250 | 25,000 | |
Jun 04 2020 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 13.85 | 25,000 | 346,250 | 25,000 | |
May 29 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 1,934,115 | 1.3 M to 1.9 M (+47.74 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | X | 8.63 | 339,604 | 2,930,783 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | X | 8.63 | 141,221 | 1,218,737 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 16,232,511 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 39,035,325 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 26,666,666 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Payment of Exercise | F | 16.00 | 183,174 | 2,930,784 | 1,288,446 | 1.5 M to 1.3 M (-12.45 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | X | 8.63 | 339,604 | 2,930,783 | 1,471,620 | 1.1 M to 1.5 M (+30.00 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Payment of Exercise | F | 16.00 | 76,172 | 1,218,752 | 1,309,115 | 1.4 M to 1.3 M (-5.50 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | X | 8.63 | 141,221 | 1,218,737 | 1,385,287 | 1.2 M to 1.4 M (+11.35 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 470,739 | 0 | 1,244,066 | 773.3 K to 1.2 M (+60.87 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 1,132,016 | 0 | 1,132,016 | 0 to 1.1 M |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 773,327 | 0 | 773,327 | 0 to 773.3 K |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
Apr 28 2020 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.10 | 9,090,909 | 10,000,000 | 55,042,456 | 46 M to 55 M (+19.78 %) |
Apr 20 2020 | CRNX | Crinetics Pharmace ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.00 | 1,071,428 | 14,999,992 | 3,659,381 | 2.6 M to 3.7 M (+41.40 %) |
Mar 23 2020 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.10 | 500,000 | 1,050,000 | 16,584,802 | 16.1 M to 16.6 M (+3.11 %) |
Mar 17 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.75 | 1,000,000 | 1,750,000 | 15,919,925 | 14.9 M to 15.9 M (+6.70 %) |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 4.67 | 700,000 | 3,269,000 | 700,000 | |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 3.74 | 700,000 | 2,618,000 | 700,000 | |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.00 | 3,000,000 | 9,000,000 | 14,919,925 | 11.9 M to 14.9 M (+25.17 %) |
Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 4,563,700 | 15,972,950 | 16,084,802 | 11.5 M to 16.1 M (+39.61 %) |
Feb 04 2020 | ALBO | ALBIREO PHARMA, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 21.00 | 255,809 | 5,371,989 | 1,960,139 | 1.7 M to 2 M (+15.01 %) |
Dec 27 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.39 | 73,698 | 1,060,514 | 11,532,467 | 11.5 M to 11.5 M (+0.64 %) |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.30 | 153,237 | 2,191,289 | 11,458,769 | 11.3 M to 11.5 M (+1.36 %) |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.14 | 189,322 | 2,677,013 | 11,305,532 | 11.1 M to 11.3 M (+1.70 %) |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.86 | 120,931 | 1,676,104 | 11,116,210 | 11 M to 11.1 M (+1.10 %) |
Dec 26 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.72 | 142,812 | 1,959,381 | 10,995,279 | 10.9 M to 11 M (+1.32 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.74 | 333,800 | 580,812 | 11,919,925 | 11.6 M to 11.9 M (+2.88 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.60 | 2,000,000 | 3,200,000 | 11,586,125 | 9.6 M to 11.6 M (+20.86 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.72 | 3,000,000 | 5,160,000 | 9,586,125 | 6.6 M to 9.6 M (+45.55 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.69 | 435,015 | 735,175 | 6,586,125 | 6.2 M to 6.6 M (+7.07 %) |
Nov 18 2019 | KDMN | Kadmon Holdings, I ... | PERCEPTIVE ADVISORS LLC | Buy | P | 3.40 | 1,470,588 | 4,999,999 | 14,636,334 | 13.2 M to 14.6 M (+11.17 %) | |
Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
Nov 12 2019 | QTNT | Quotient Ltd | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 7.00 | 2,500,000 | 17,500,000 | 13,289,054 | 10.8 M to 13.3 M (+23.17 %) |
Oct 31 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 0.44 | 760,291 | 334,528 | 6,151,110 | 6.9 M to 6.2 M (-11.00 %) |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 0.51 | 3,815,349 | 1,945,828 | 6,911,401 | 10.7 M to 6.9 M (-35.57 %) |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.95 | 2,300,000 | 2,185,000 | 10,726,750 | 8.4 M to 10.7 M (+27.29 %) |
Oct 21 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.93 | 50,000 | 546,500 | 10,852,467 | 10.8 M to 10.9 M (+0.46 %) |
Oct 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 10.29 | 67,222 | 691,714 | 10,802,467 | 10.7 M to 10.8 M (+0.63 %) |
Sep 24 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.50 | 20,000,000 | 10,000,000 | 45,951,556 | 26 M to 46 M (+77.07 %) |
Sep 18 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.58 | 30,000 | 407,400 | 10,735,245 | 10.7 M to 10.7 M (+0.28 %) |
Sep 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.27 | 56,416 | 805,056 | 10,705,245 | 10.6 M to 10.7 M (+0.53 %) |
Sep 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.05 | 13,584 | 190,855 | 10,648,829 | 10.6 M to 10.6 M (+0.13 %) |
Aug 20 2019 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 23.50 | 425,531 | 9,999,979 | 6,433,277 | 6 M to 6.4 M (+7.08 %) |
Aug 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.96 | 20,000 | 299,200 | 10,635,245 | 10.6 M to 10.6 M (+0.19 %) |
Aug 16 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.00 | 30,000 | 450,000 | 10,615,245 | 10.6 M to 10.6 M (+0.28 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.76 | 30,000 | 472,800 | 10,585,245 | 10.6 M to 10.6 M (+0.28 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.79 | 37,764 | 596,294 | 10,555,245 | 10.5 M to 10.6 M (+0.36 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 15.04 | 248,752 | 3,741,230 | 10,517,481 | 10.3 M to 10.5 M (+2.42 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.14 | 371,756 | 5,256,630 | 10,268,729 | 9.9 M to 10.3 M (+3.76 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.12 | 74,855 | 982,098 | 9,896,973 | 9.8 M to 9.9 M (+0.76 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.89 | 1,495 | 26,746 | 9,822,118 | 9.8 M to 9.8 M (+0.02 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.90 | 20,786 | 372,069 | 9,820,623 | 9.8 M to 9.8 M (+0.21 %) |
Aug 09 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.85 | 23,073 | 411,853 | 9,799,837 | 9.8 M to 9.8 M (+0.24 %) |
Jul 29 2019 | SLDB | Solid Biosciences ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 4.65 | 2,822,581 | 13,125,002 | 6,749,803 | 3.9 M to 6.7 M (+71.87 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.67 | 42,916 | 715,410 | 3,708,705 | 3.7 M to 3.7 M (+1.17 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.89 | 12,354 | 208,659 | 3,665,789 | 3.7 M to 3.7 M (+0.34 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.67 | 42,916 | 715,410 | 3,708,705 | 3.7 M to 3.7 M (+1.17 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.61 | 29,834 | 495,543 | 3,653,435 | 3.6 M to 3.7 M (+0.82 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.89 | 12,354 | 208,659 | 3,665,789 | 3.7 M to 3.7 M (+0.34 %) |
Jul 11 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.61 | 29,834 | 495,543 | 3,653,435 | 3.6 M to 3.7 M (+0.82 %) |
Jul 09 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.46 | 50,000 | 823,000 | 3,632,601 | 3.6 M to 3.6 M (+1.40 %) |
Jul 03 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.67 | 1,705 | 28,422 | 3,573,601 | 3.6 M to 3.6 M (+0.05 %) |
Jul 03 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 16.14 | 715 | 11,540 | 3,571,896 | 3.6 M to 3.6 M (+0.02 %) |
Jul 03 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.24 | 18,121 | 258,043 | 3,571,181 | 3.6 M to 3.6 M (+0.51 %) |
Jul 01 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 14.48 | 39,383 | 570,266 | 3,553,060 | 3.5 M to 3.6 M (+1.12 %) |
Jul 01 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.97 | 60,617 | 846,819 | 3,513,560 | 3.5 M to 3.5 M (+1.76 %) |
Jul 01 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 13.58 | 186,696 | 2,535,332 | 3,453,060 | 3.3 M to 3.5 M (+5.72 %) |
Jul 01 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 12.46 | 140,513 | 1,750,792 | 3,266,364 | 3.1 M to 3.3 M (+4.50 %) |
Jul 01 2019 | MOTS | Motus GI Holdings, ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.00 | 1,000,000 | 3,000,000 | 4,210,542 | 3.2 M to 4.2 M (+31.15 %) |
Jun 21 2019 | MGTX | MeiraGTx Holdings ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 21.28 | 25,000 | 532,000 | 25,000 | |
Jun 20 2019 | ATNX | Athenex, Inc. | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.73 | 50,742 | 899,656 | 9,776,764 | 9.7 M to 9.8 M (+0.52 %) |
Jun 20 2019 | VBIV | VBI Vaccines Inc/B ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.65 | 1,000,000 | 650,000 | 25,951,556 | 25 M to 26 M (+4.01 %) |